PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3beta inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).
Molecular Weight:
422.48
Purity:
99.73
CAS Number:
[2733575-91-0]
Formula:
C19H30N6O5
Target:
CDK,GSK-3
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted